. | Death (n = 41 873) . | Amputation (n = 41 860) . | MI (n = 41 860) . | Ischaemic stroke (n = 41 873) . | ||||
---|---|---|---|---|---|---|---|---|
. | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
RF 1–3 | 1 | 1 | 1 | 1 | ||||
RF 4 | 2.04 (1.91–2.18) | <0.001 | 3.11 (2.76–3.49) | <0.001 | 1.32 (1.15–1.51) | <0.001 | 1.43 (1.23–1.65) | <0.001 |
RF 5 | 2.53 (2.39–2.68) | <0.001 | 9.28 (8.47–10.17) | <0.001 | 1.29 (1.14–1.47) | <0.001 | 1.32 (1.15–1.51) | <0.001 |
RF 6 | 3.75 (3.56–3.96) | <0.001 | 29.00 (26.67–31.55) | <0.001 | 1.29 (1.14–1.46) | <0.001 | 1.50 (1.32–1.72) | <0.001 |
Age | 1.06 (1.06–1.06) | <0.001 | 1.00 (1.00–1.00) | 0.157 | 1.02 (1.02–1.03) | <0.001 | 1.03 (1.03–1.04) | <0.001 |
Male | 1.21 (1.16–1.25) | <0.001 | 1.33 (1.27–1.39) | <0.001 | 1.27 (1.16–1.40) | <0.001 | 1.07 (0.96–1.18) | 0.226 |
Hypertension | 0.83 (0.79–0.86) | <0.001 | 0.93 (0.89–0.98) | 0.003 | 0.91 (0.82–1.00) | 0.059 | 1.07 (0.96–1.20) | 0.229 |
Obesity | 0.88 (0.81–0.95) | 0.002 | 0.93 (0.86–1.01) | 0.104 | 1.03 (0.88–1.21) | 0.729 | 0.98 (0.81–1.18) | 0.825 |
Dyslipidaemia | 0.74 (0.70–0.77) | <0.001 | 0.84 (0.80–0.89) | <0.001 | 0.92 (0.83–1.01) | 0.091 | 0.91 (0.81–1.01) | 0.083 |
Smoking | 1.05 (0.97–1.14) | 0.265 | 0.835 (0.76–0.92) | <0.001 | 0.99 (0.85–1.18) | 0.989 | 1.07 (0.90–1.28) | 0.446 |
Diabetes | 1.05 (1.00–1.09) | 0.033 | 1.473 (1.41–1.54) | <0.001 | 1.28 (1.17–1.41) | <0.001 | 1.30 (1.17–1.44) | <0.001 |
CAD | 1.24 (1.19–1.30) | <0.001 | 1.00 (0.95–1.05) | 0.976 | 2.02 (1.84–2.22) | <0.001 | 0.97 (0.86–1.09) | 0.554 |
CHF | 1.62 (1.54–1.70) | <0.001 | 1.10 (1.03–1.17) | 0.003 | 1.64 (1.44–1.85) | <0.001 | 1.27 (1.09–1.49) | 0.002 |
CKD | 1.47 (1.41–1.53) | <0.001 | 1.12 (1.07–1.18) | <0.001 | 1.30 (1.17–1.44) | <0.001 | 1.05 (0.93–1.18) | 0.439 |
Malignancies | 2.16 (1.96–2.38) | <0.001 | 0.91 (0.78–1.05) | 0.203 | 1.14 (0.82–1.58) | 0.428 | 0.97 (0.65–1.44) | 0.874 |
Harrell's Ca | 0.78 | 0.85 | 0.68 | 0.64 |
. | Death (n = 41 873) . | Amputation (n = 41 860) . | MI (n = 41 860) . | Ischaemic stroke (n = 41 873) . | ||||
---|---|---|---|---|---|---|---|---|
. | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
RF 1–3 | 1 | 1 | 1 | 1 | ||||
RF 4 | 2.04 (1.91–2.18) | <0.001 | 3.11 (2.76–3.49) | <0.001 | 1.32 (1.15–1.51) | <0.001 | 1.43 (1.23–1.65) | <0.001 |
RF 5 | 2.53 (2.39–2.68) | <0.001 | 9.28 (8.47–10.17) | <0.001 | 1.29 (1.14–1.47) | <0.001 | 1.32 (1.15–1.51) | <0.001 |
RF 6 | 3.75 (3.56–3.96) | <0.001 | 29.00 (26.67–31.55) | <0.001 | 1.29 (1.14–1.46) | <0.001 | 1.50 (1.32–1.72) | <0.001 |
Age | 1.06 (1.06–1.06) | <0.001 | 1.00 (1.00–1.00) | 0.157 | 1.02 (1.02–1.03) | <0.001 | 1.03 (1.03–1.04) | <0.001 |
Male | 1.21 (1.16–1.25) | <0.001 | 1.33 (1.27–1.39) | <0.001 | 1.27 (1.16–1.40) | <0.001 | 1.07 (0.96–1.18) | 0.226 |
Hypertension | 0.83 (0.79–0.86) | <0.001 | 0.93 (0.89–0.98) | 0.003 | 0.91 (0.82–1.00) | 0.059 | 1.07 (0.96–1.20) | 0.229 |
Obesity | 0.88 (0.81–0.95) | 0.002 | 0.93 (0.86–1.01) | 0.104 | 1.03 (0.88–1.21) | 0.729 | 0.98 (0.81–1.18) | 0.825 |
Dyslipidaemia | 0.74 (0.70–0.77) | <0.001 | 0.84 (0.80–0.89) | <0.001 | 0.92 (0.83–1.01) | 0.091 | 0.91 (0.81–1.01) | 0.083 |
Smoking | 1.05 (0.97–1.14) | 0.265 | 0.835 (0.76–0.92) | <0.001 | 0.99 (0.85–1.18) | 0.989 | 1.07 (0.90–1.28) | 0.446 |
Diabetes | 1.05 (1.00–1.09) | 0.033 | 1.473 (1.41–1.54) | <0.001 | 1.28 (1.17–1.41) | <0.001 | 1.30 (1.17–1.44) | <0.001 |
CAD | 1.24 (1.19–1.30) | <0.001 | 1.00 (0.95–1.05) | 0.976 | 2.02 (1.84–2.22) | <0.001 | 0.97 (0.86–1.09) | 0.554 |
CHF | 1.62 (1.54–1.70) | <0.001 | 1.10 (1.03–1.17) | 0.003 | 1.64 (1.44–1.85) | <0.001 | 1.27 (1.09–1.49) | 0.002 |
CKD | 1.47 (1.41–1.53) | <0.001 | 1.12 (1.07–1.18) | <0.001 | 1.30 (1.17–1.44) | <0.001 | 1.05 (0.93–1.18) | 0.439 |
Malignancies | 2.16 (1.96–2.38) | <0.001 | 0.91 (0.78–1.05) | 0.203 | 1.14 (0.82–1.58) | 0.428 | 0.97 (0.65–1.44) | 0.874 |
Harrell's Ca | 0.78 | 0.85 | 0.68 | 0.64 |
CAD, coronary artery disease; CHF, chronic heart failure, CKD, chronic kidney disease; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; RF, Rutherford category.
Comorbidities were defined on the basis of given ICD-10 codes, and are presented in detail in Supplementary material online, Table S1.
Significant P-values were presented in bold.
aA value for Harrell's C = 0.5 suggests no discrimination; 0.7 ≤ C < 0.8 is considered acceptable discrimination; 0.8 ≤ C < 0.9 is considered as excellent discrimination; C ≥ 0.9 is considered as outstanding discrimination.
. | Death (n = 41 873) . | Amputation (n = 41 860) . | MI (n = 41 860) . | Ischaemic stroke (n = 41 873) . | ||||
---|---|---|---|---|---|---|---|---|
. | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
RF 1–3 | 1 | 1 | 1 | 1 | ||||
RF 4 | 2.04 (1.91–2.18) | <0.001 | 3.11 (2.76–3.49) | <0.001 | 1.32 (1.15–1.51) | <0.001 | 1.43 (1.23–1.65) | <0.001 |
RF 5 | 2.53 (2.39–2.68) | <0.001 | 9.28 (8.47–10.17) | <0.001 | 1.29 (1.14–1.47) | <0.001 | 1.32 (1.15–1.51) | <0.001 |
RF 6 | 3.75 (3.56–3.96) | <0.001 | 29.00 (26.67–31.55) | <0.001 | 1.29 (1.14–1.46) | <0.001 | 1.50 (1.32–1.72) | <0.001 |
Age | 1.06 (1.06–1.06) | <0.001 | 1.00 (1.00–1.00) | 0.157 | 1.02 (1.02–1.03) | <0.001 | 1.03 (1.03–1.04) | <0.001 |
Male | 1.21 (1.16–1.25) | <0.001 | 1.33 (1.27–1.39) | <0.001 | 1.27 (1.16–1.40) | <0.001 | 1.07 (0.96–1.18) | 0.226 |
Hypertension | 0.83 (0.79–0.86) | <0.001 | 0.93 (0.89–0.98) | 0.003 | 0.91 (0.82–1.00) | 0.059 | 1.07 (0.96–1.20) | 0.229 |
Obesity | 0.88 (0.81–0.95) | 0.002 | 0.93 (0.86–1.01) | 0.104 | 1.03 (0.88–1.21) | 0.729 | 0.98 (0.81–1.18) | 0.825 |
Dyslipidaemia | 0.74 (0.70–0.77) | <0.001 | 0.84 (0.80–0.89) | <0.001 | 0.92 (0.83–1.01) | 0.091 | 0.91 (0.81–1.01) | 0.083 |
Smoking | 1.05 (0.97–1.14) | 0.265 | 0.835 (0.76–0.92) | <0.001 | 0.99 (0.85–1.18) | 0.989 | 1.07 (0.90–1.28) | 0.446 |
Diabetes | 1.05 (1.00–1.09) | 0.033 | 1.473 (1.41–1.54) | <0.001 | 1.28 (1.17–1.41) | <0.001 | 1.30 (1.17–1.44) | <0.001 |
CAD | 1.24 (1.19–1.30) | <0.001 | 1.00 (0.95–1.05) | 0.976 | 2.02 (1.84–2.22) | <0.001 | 0.97 (0.86–1.09) | 0.554 |
CHF | 1.62 (1.54–1.70) | <0.001 | 1.10 (1.03–1.17) | 0.003 | 1.64 (1.44–1.85) | <0.001 | 1.27 (1.09–1.49) | 0.002 |
CKD | 1.47 (1.41–1.53) | <0.001 | 1.12 (1.07–1.18) | <0.001 | 1.30 (1.17–1.44) | <0.001 | 1.05 (0.93–1.18) | 0.439 |
Malignancies | 2.16 (1.96–2.38) | <0.001 | 0.91 (0.78–1.05) | 0.203 | 1.14 (0.82–1.58) | 0.428 | 0.97 (0.65–1.44) | 0.874 |
Harrell's Ca | 0.78 | 0.85 | 0.68 | 0.64 |
. | Death (n = 41 873) . | Amputation (n = 41 860) . | MI (n = 41 860) . | Ischaemic stroke (n = 41 873) . | ||||
---|---|---|---|---|---|---|---|---|
. | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . | HR (95% CI) . | P . |
RF 1–3 | 1 | 1 | 1 | 1 | ||||
RF 4 | 2.04 (1.91–2.18) | <0.001 | 3.11 (2.76–3.49) | <0.001 | 1.32 (1.15–1.51) | <0.001 | 1.43 (1.23–1.65) | <0.001 |
RF 5 | 2.53 (2.39–2.68) | <0.001 | 9.28 (8.47–10.17) | <0.001 | 1.29 (1.14–1.47) | <0.001 | 1.32 (1.15–1.51) | <0.001 |
RF 6 | 3.75 (3.56–3.96) | <0.001 | 29.00 (26.67–31.55) | <0.001 | 1.29 (1.14–1.46) | <0.001 | 1.50 (1.32–1.72) | <0.001 |
Age | 1.06 (1.06–1.06) | <0.001 | 1.00 (1.00–1.00) | 0.157 | 1.02 (1.02–1.03) | <0.001 | 1.03 (1.03–1.04) | <0.001 |
Male | 1.21 (1.16–1.25) | <0.001 | 1.33 (1.27–1.39) | <0.001 | 1.27 (1.16–1.40) | <0.001 | 1.07 (0.96–1.18) | 0.226 |
Hypertension | 0.83 (0.79–0.86) | <0.001 | 0.93 (0.89–0.98) | 0.003 | 0.91 (0.82–1.00) | 0.059 | 1.07 (0.96–1.20) | 0.229 |
Obesity | 0.88 (0.81–0.95) | 0.002 | 0.93 (0.86–1.01) | 0.104 | 1.03 (0.88–1.21) | 0.729 | 0.98 (0.81–1.18) | 0.825 |
Dyslipidaemia | 0.74 (0.70–0.77) | <0.001 | 0.84 (0.80–0.89) | <0.001 | 0.92 (0.83–1.01) | 0.091 | 0.91 (0.81–1.01) | 0.083 |
Smoking | 1.05 (0.97–1.14) | 0.265 | 0.835 (0.76–0.92) | <0.001 | 0.99 (0.85–1.18) | 0.989 | 1.07 (0.90–1.28) | 0.446 |
Diabetes | 1.05 (1.00–1.09) | 0.033 | 1.473 (1.41–1.54) | <0.001 | 1.28 (1.17–1.41) | <0.001 | 1.30 (1.17–1.44) | <0.001 |
CAD | 1.24 (1.19–1.30) | <0.001 | 1.00 (0.95–1.05) | 0.976 | 2.02 (1.84–2.22) | <0.001 | 0.97 (0.86–1.09) | 0.554 |
CHF | 1.62 (1.54–1.70) | <0.001 | 1.10 (1.03–1.17) | 0.003 | 1.64 (1.44–1.85) | <0.001 | 1.27 (1.09–1.49) | 0.002 |
CKD | 1.47 (1.41–1.53) | <0.001 | 1.12 (1.07–1.18) | <0.001 | 1.30 (1.17–1.44) | <0.001 | 1.05 (0.93–1.18) | 0.439 |
Malignancies | 2.16 (1.96–2.38) | <0.001 | 0.91 (0.78–1.05) | 0.203 | 1.14 (0.82–1.58) | 0.428 | 0.97 (0.65–1.44) | 0.874 |
Harrell's Ca | 0.78 | 0.85 | 0.68 | 0.64 |
CAD, coronary artery disease; CHF, chronic heart failure, CKD, chronic kidney disease; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; RF, Rutherford category.
Comorbidities were defined on the basis of given ICD-10 codes, and are presented in detail in Supplementary material online, Table S1.
Significant P-values were presented in bold.
aA value for Harrell's C = 0.5 suggests no discrimination; 0.7 ≤ C < 0.8 is considered acceptable discrimination; 0.8 ≤ C < 0.9 is considered as excellent discrimination; C ≥ 0.9 is considered as outstanding discrimination.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.